Evaluation of the Value of Attribution in the Interpretation of Adverse Event Data: A North Central Cancer Treatment Group and American College of Surgeons Oncology Group Investigation

PURPOSE: In March 1998, Common Toxicity Criteria (CTC) version 2.0 introduced the collection of attribution of adverse events (AEs) to study drug. We investigate whether attribution adds value to the interpretation of AE data. PATIENTS AND METHODS: Patients in the placebo arm of two phase III trials...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hillman, Shauna L., Mandrekar, Sumithra J., Bot, Brian, DeMatteo, Ronald P., Perez, Edith A., Ballman, Karla V., Nelson, Heidi, Buckner, Jan C., Sargent, Daniel J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903334/
https://ncbi.nlm.nih.gov/pubmed/20479400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.4282
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados